Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals
Direct antiviral agents (DAAs) have excellent efficacy against chronic hepatitis C virus (HCV) infection. Despite this strength, recent studies raised concerns about an unexpected hepatocellular carcinoma (HCC) occurrence rate after DAA therapy. In this exploratory case-control study, we evaluated t...
Main Authors: | Devis Pascut, Luisa Cavalletto, Muhammad Yogi Pratama, Silvia Bresolin, Luca Trentin, Giuseppe Basso, Giorgio Bedogni, Claudio Tiribelli, Liliana Chemello |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/11/1773 |
Similar Items
-
HCV Proteins Modulate the Host Cell miRNA Expression Contributing to Hepatitis C Pathogenesis and Hepatocellular Carcinoma Development
by: Devis Pascut, et al.
Published: (2021-05-01) -
Aggressive recurrence of Non-Hodgkin's Lymphoma after successful clearance of hepatitis C virus with direct acting antivirals
by: Dimitrios N. Samonakis, et al.
Published: (2021-03-01) -
Vascular endothelial growth factor in relation to the development of hepatocellular carcinoma in hepatitis C virus patients treated by direct-acting antivirals
by: Ahmed Mohamed ElGhandour, et al.
Published: (2021-01-01) -
HCC in the Era of Direct-Acting Antiviral Agents (DAAs): Surgical and Other Curative or Palliative Strategies in the Elderly
by: Stefania Brozzetti, et al.
Published: (2021-06-01) -
Decreased Incidence of Hepatocellular Carcinoma after Directly Acting Antiviral Therapy in Patients with Hepatitis C–Related Advanced Fibrosis and Cirrhosis
by: Kilany S, et al.
Published: (2021-08-01)